Efficacy of Cerebral Embolic Protection Devices to Reduce Stroke During TAVR

Monday, March 9, 2026

1:46 PM - 1:54 PM EST

Location: Cabinet

Speaker(s)

Neel Butala, MD

Medical Director of Structural Heart Disease and Intervention
Rocky Mountain Regional VA Medical Center

Disclosure(s): Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); Emboline, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Neel Butala, MD: Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); Emboline, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing)